Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes

被引:53
作者
Crandall, DL
Quinet, EM
Morgan, GA
Busler, DE
McHendry-Rinde, B
Kral, JG
机构
[1] Wyeth Ayerst Labs Inc, Res, Radnor, PA USA
[2] Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA
关键词
D O I
10.1210/jc.84.9.3222
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To further investigate the role of plasminogen activator inhibitor-1 (PAI-1) in adipose tissue physiology, the production and regulation of PAI-1 was determined in primary cultures of human preadipocytes. When expressed as production per cell and cultured under identical conditions, human preadipocytes from both visceral (omental) and sc depots of lean and obese individuals released significant, yet similar, amounts of PAI-1 protein into the conditioned medium. High steady-state PAI-1 messenger RNA (mRNA) concentrations were observed in visceral and sc preadipocytes, with the relative level of expression equivalent to beta-actin mRNA. Tumor necrosis factor alpha significantly decreased PAI-1 production in a concentration-dependent manner in both visceral and sc cultures, whereas transforming growth factor beta significantly elevated PAI-1 production, but only in se preadipocytes from obese individuals. Addition of insulin had no effect on antigen levels in conditioned medium of preadipocyte cultures. Stimulation of the preadipocyte cultures with a defined medium resulted in differentiation to the adipocyte phenotype, as determined by flow cytometric analysis, verifying the cultures as human preadipocyte. These studies are the first to observe significant PAI-1 mRNA expression and protein production in primary cultures of a human adipose tissue cellular component, and they suggest that nascent adipocytes contribute significantly to the elevated plasma PAI-1 observed in obesity.
引用
收藏
页码:3222 / 3227
页数:6
相关论文
共 32 条
  • [1] ALESSI MC, 1988, THROMB HAEMOSTASIS, V60, P491
  • [2] Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease
    Alessi, MC
    Peiretti, F
    Morange, P
    Henry, M
    Nalbone, G
    JuhanVague, I
    [J]. DIABETES, 1997, 46 (05) : 860 - 867
  • [3] Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
    Bajou, K
    Noël, A
    Gerard, RD
    Masson, V
    Brunner, N
    Holst-Hansen, C
    Skobe, M
    Fusenig, NE
    Carmeliet, P
    Collen, D
    Foidart, JM
    [J]. NATURE MEDICINE, 1998, 4 (08) : 923 - 928
  • [4] BASTARD JP, 1995, INT J OBESITY, V19, P836
  • [5] Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells
    Chen, YQ
    Su, M
    Walia, RR
    Hao, Q
    Covington, JW
    Vaughan, DE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) : 8225 - 8231
  • [6] Angiotensin II receptors in human preadipocytes: Role in cell cycle regulation
    Crandall, DL
    Armellino, DC
    Busler, DE
    McHendry-Rinde, B
    Kral, JG
    [J]. ENDOCRINOLOGY, 1999, 140 (01) : 154 - 158
  • [7] A review of the microcirculation of adipose tissue: Anatomic, metabolic and angiogenic perspectives
    Crandall, DL
    Hausman, GJ
    Kral, JG
    [J]. MICROCIRCULATION-LONDON, 1997, 4 (02): : 211 - 232
  • [8] CRANDALL DL, 1991, OBESITY EUROPE, P405
  • [9] Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
    Deng, G
    Curriden, SA
    Wang, SJ
    Rosenberg, S
    Loskutoff, DJ
    [J]. JOURNAL OF CELL BIOLOGY, 1996, 134 (06) : 1563 - 1571
  • [10] Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals
    Eriksson, P
    Reynisdottir, S
    Lönnqvist, F
    Stemme, V
    Hamsten, A
    Arner, P
    [J]. DIABETOLOGIA, 1998, 41 (01) : 65 - 71